FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308231377> ?p ?o ?g. }

• W4308231377 abstract "Abstract Background The present work was carried out with the objective of evaluating the effects on inflammatory factors and on the consumption of resources in health care, in anti-coagulated patients with apixaban or acenocoumarol, treated with electric cardioversion ambulatory (ECV). Methods 236 patients with non-valvular atrial fibrillation (NVAF), who underwent ambulatory CVE between April 2017 and October 2020, were prospectively analyzed. The levels of IL-6, TNF-α, IL-10 and TGF-β were measured before cardioversion and one month after cardioversion. Results The mean age of the study population was 71 years, 52% with a history of NVAF prior to the index event. The procedure was successful in 90% of the patients (n = 210). The average number of shocks per patient was 1.39 joules. A transesophageal echocardiogram was performed in 236 patients (100%), which revealed thrombus in the left atrium in 2 of them. Among the anticoagulated patients with acenocoumarol (N 50), 7 patients (14%) with sub-optimal INR were registered, who were reprogrammed for ECV. The delay time until performing the CVE was 30 ± 7, with an impact on the waiting list of 2 months. A statistically significant decrease in the apixaban treatment arm was recorded in the assessment of pro-inflammatory cytokine levels. Conclusions Ambulatory ECV is a safe and effective method for the treatment of NVAF in patients anticoagulated with apixaban or acenocoumarol. An advantage of the use of DOAC (Direct Oral Anticoagulant) in the context of peri-cardioversion is to avoid inadequate control of the INR, a frequent reason for suspending scheduled electrical cardioversions, increased of waiting lists and healthcare costs. Apixaban showed a decrease in levels of pro-inflammatory factors (IL6 - TNF-α). This effect could be related with prediction of mortality risk as other studies have shown." @default.
• W4308231377 created "2022-11-09" @default.
• W4308231377 creator A5000876864 @default.
• W4308231377 creator A5005362681 @default.
• W4308231377 creator A5019781101 @default.
• W4308231377 creator A5027780874 @default.
• W4308231377 creator A5036786997 @default.
• W4308231377 creator A5048349619 @default.
• W4308231377 creator A5068665100 @default.
• W4308231377 creator A5076052495 @default.
• W4308231377 creator A5082166062 @default.
• W4308231377 date "2022-11-03" @default.
• W4308231377 modified "2023-10-01" @default.
• W4308231377 title "Experience with Apixaban Versus Acenocumarol in Usual Clinical Practice in Patients with Persistent Non-Valvular Atrial Fibrillation Treated with Electric Cardioversion Ambulatory" @default.
• W4308231377 cites W1981285115 @default.
• W4308231377 cites W1999468381 @default.
• W4308231377 cites W206978033 @default.
• W4308231377 cites W2085270509 @default.
• W4308231377 cites W2089534375 @default.
• W4308231377 cites W2090462746 @default.
• W4308231377 cites W2098758542 @default.
• W4308231377 cites W2129155820 @default.
• W4308231377 cites W2144891869 @default.
• W4308231377 cites W2162508946 @default.
• W4308231377 cites W2164861810 @default.
• W4308231377 cites W2328630984 @default.
• W4308231377 cites W2795632834 @default.
• W4308231377 cites W2897858334 @default.
• W4308231377 cites W2945664349 @default.
• W4308231377 cites W2949679206 @default.
• W4308231377 cites W3033026575 @default.
• W4308231377 cites W3037284376 @default.
• W4308231377 cites W3082188176 @default.
• W4308231377 cites W3096971711 @default.
• W4308231377 cites W4233697107 @default.
• W4308231377 doi "https://doi.org/10.21203/rs.3.rs-2196399/v1" @default.
• W4308231377 hasPublicationYear "2022" @default.
• W4308231377 type Work @default.
• W4308231377 citedByCount "0" @default.
• W4308231377 crossrefType "posted-content" @default.
• W4308231377 hasAuthorship W4308231377A5000876864 @default.
• W4308231377 hasAuthorship W4308231377A5005362681 @default.
• W4308231377 hasAuthorship W4308231377A5019781101 @default.
• W4308231377 hasAuthorship W4308231377A5027780874 @default.
• W4308231377 hasAuthorship W4308231377A5036786997 @default.
• W4308231377 hasAuthorship W4308231377A5048349619 @default.
• W4308231377 hasAuthorship W4308231377A5068665100 @default.
• W4308231377 hasAuthorship W4308231377A5076052495 @default.
• W4308231377 hasAuthorship W4308231377A5082166062 @default.
• W4308231377 hasBestOaLocation W43082313771 @default.
• W4308231377 hasConcept C126322002 @default.
• W4308231377 hasConcept C151730666 @default.
• W4308231377 hasConcept C164705383 @default.
• W4308231377 hasConcept C2776301958 @default.
• W4308231377 hasConcept C2777289489 @default.
• W4308231377 hasConcept C2778661090 @default.
• W4308231377 hasConcept C2779161974 @default.
• W4308231377 hasConcept C2779343474 @default.
• W4308231377 hasConcept C2780638905 @default.
• W4308231377 hasConcept C2781344064 @default.
• W4308231377 hasConcept C35785553 @default.
• W4308231377 hasConcept C71924100 @default.
• W4308231377 hasConcept C86803240 @default.
• W4308231377 hasConceptScore W4308231377C126322002 @default.
• W4308231377 hasConceptScore W4308231377C151730666 @default.
• W4308231377 hasConceptScore W4308231377C164705383 @default.
• W4308231377 hasConceptScore W4308231377C2776301958 @default.
• W4308231377 hasConceptScore W4308231377C2777289489 @default.
• W4308231377 hasConceptScore W4308231377C2778661090 @default.
• W4308231377 hasConceptScore W4308231377C2779161974 @default.
• W4308231377 hasConceptScore W4308231377C2779343474 @default.
• W4308231377 hasConceptScore W4308231377C2780638905 @default.
• W4308231377 hasConceptScore W4308231377C2781344064 @default.
• W4308231377 hasConceptScore W4308231377C35785553 @default.
• W4308231377 hasConceptScore W4308231377C71924100 @default.
• W4308231377 hasConceptScore W4308231377C86803240 @default.
• W4308231377 hasLocation W43082313771 @default.
• W4308231377 hasOpenAccess W4308231377 @default.
• W4308231377 hasPrimaryLocation W43082313771 @default.
• W4308231377 hasRelatedWork W2049310472 @default.
• W4308231377 hasRelatedWork W2049346164 @default.
• W4308231377 hasRelatedWork W206978033 @default.
• W4308231377 hasRelatedWork W2225807237 @default.
• W4308231377 hasRelatedWork W2245558837 @default.
• W4308231377 hasRelatedWork W2589278081 @default.
• W4308231377 hasRelatedWork W2597099584 @default.
• W4308231377 hasRelatedWork W2789710191 @default.
• W4308231377 hasRelatedWork W2927311145 @default.
• W4308231377 hasRelatedWork W1570353559 @default.
• W4308231377 isParatext "false" @default.
• W4308231377 isRetracted "false" @default.
• W4308231377 workType "article" @default.